Skip to main content

Table 4 Frequencies of beta-lactam resistance and clinical characteristics in study groups and in the original population a

From: Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae

  

rPBP3c

Bla d

Proportions (%) of isolates and patients

Groups of isolatesb

n

n

%

n

%

Anatomical sites

Age groups

Hospitalizede

      

Eye

Ear

Respiratory

0-3

≥50

 

Resistant group

177

116

66

16

9

28

10

58

44

24

33

Susceptible group

19

0

0

0

0

21

32

42

68

5

11

Remaining isolates

599

0f

0f

60g

10g

19

15

63

41

22

23

Original population

795h

116

15

76

10

21

14

62

43

22

25

  1. aNORM 2007 surveillance population [33], consisting of consecutive routine isolates from patients with eye, ear and respiratory tract infections.
  2. bSee text and Figure 1 for definition of the study groups (Resistant group and Susceptible group).
  3. cPBP3-mediated resistance (see Table 1).
  4. dBeta-lactamase positive.
  5. eProportions of patients hospitalized at the time of sampling.
  6. fAssuming that all rPBP3 isolates were selected for the Resistant group.
  7. gAs reported by the primary laboratories.
  8. hThirteen isolates were selected for the Resistant group but excluded for various reasons (see Figure 1).